<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18701582</PMID><DateCompleted><Year>2008</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-959X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>9</Issue><PubDate><Year>2008</Year><Month>Oct</Month></PubDate></JournalIssue><Title>AJNR. American journal of neuroradiology</Title><ISOAbbreviation>AJNR Am J Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Combined 3T diffusion tensor tractography and 1H-MR spectroscopy in motor neuron disease.</ArticleTitle><Pagination><StartPage>1708</StartPage><EndPage>1714</EndPage><MedlinePgn>1708-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3174/ajnr.A1201</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Diagnostic confidence in motor neuron disease may be improved by the use of advanced MR imaging techniques. Our aim was to assess the accuracy (sensitivity/specificity) and agreement of combined (1)H-MR spectroscopy (proton MR spectroscopy) and diffusion tensor imaging (DTI) at 3T in patients with suspected motor neuron disease regarding detection of upper motor neuron (UMN) dysfunction.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Eighteen patients with suspected motor neuron disease were studied with MR spectroscopy/DTI and clinically rated according to the El-Escorial and ALSFRS-R scales. For MR spectroscopy, absolute N-acetylaspartate (NAA), choline (Cho), and phosphocreatine (PCr) concentrations and relative NAA/Cho and NAA/PCr ratios of corresponding volumes of interest within the primary motor cortex were calculated. For DTI, fractional anisotropy (FA) and mean diffusivity (MD) were measured bilaterally at the level of the precentral gyrus, corona radiata, internal capsule, cerebral peduncles, pons, and pyramid. FA and MD statistics were averaged on the corticospinal tracts (CSTs) as a whole to account for a region-independent analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">MR spectroscopy indicated NAA reduction beyond the double SD of controls in 6 of 8 patients with clinical evidence for UMN involvement. Congruently, the mean FA of these patients was significantly lower in the upper 3 regions of measurements (P &lt; .01). Overall, MR spectroscopy and DTI were concordant in all except 3 cases: 1 was correctly excluded from motor neuron disease by DTI (genetically proved Kennedy syndrome), whereas MR spectroscopy indicated CST involvement. MR spectroscopy and DTI each were false-positive for CST affection in 1 patient with lower motor neuron involvement only.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Combined MR spectroscopy/DTI at 3T effectively adds to the detection of motor neuron disease with a high degree of accordance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nelles</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Bonn Medical Center, Bonn, Germany. michael.nelles@ukb.uni-bonn.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Block</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Tr&#xe4;ber</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>W&#xfc;llner</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Schild</LastName><ForeName>H H</ForeName><Initials>HH</Initials></Author><Author ValidYN="Y"><LastName>Urbach</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJNR Am J Neuroradiol</MedlineTA><NlmUniqueID>8003708</NlmUniqueID><ISSNLinking>0195-6108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>020IUV4N33</RegistryNumber><NameOfSubstance UI="D010725">Phosphocreatine</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>997-55-7</RegistryNumber><NameOfSubstance UI="C000179">N-acetylaspartate</NameOfSubstance></Chemical><Chemical><RegistryNumber>N91BDP6H0X</RegistryNumber><NameOfSubstance UI="D002794">Choline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016880" MajorTopicYN="N">Anisotropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002794" MajorTopicYN="N">Choline</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038524" MajorTopicYN="N">Diffusion Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004292" MajorTopicYN="N">Dominance, Cerebral</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010725" MajorTopicYN="N">Phosphocreatine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>8</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>12</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>8</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18701582</ArticleId><ArticleId IdType="pmc">PMC8118765</ArticleId><ArticleId IdType="doi">10.3174/ajnr.A1201</ArticleId><ArticleId IdType="pii">ajnr.A1201</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strong M, Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:136&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">13129799</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Urban PP, Wicht S, Hopf HC. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in Amyotrophic Lateral Sclerosis (ALS). J Neurol 2001;248:850&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">11697520</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhler R, Magistris MR, Truffert A, et al. The triple stimulation technique to study central motor conduction to the lower limbs. Clin Neurophysiol 2001;112:938&#x2013;49</Citation><ArticleIdList><ArticleId IdType="pubmed">11336912</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function: BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Block W, Karitzky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998;55:931&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pubmed">9678310</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C, Block W, Traber F, et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001;190:21&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">11574102</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C, Block W, Karitzky J, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001;58:729&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">11346367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis CM, Simmons A, Andrews C, et al. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51:1104&#x2013;09</Citation><ArticleIdList><ArticleId IdType="pubmed">9781537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, Cashman NR, Genge A, et al. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">9665596</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Giannelli M, Siciliano G, et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005;237:258&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pubmed">16183935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis CM, Simmons A, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999;53:1051&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">10496265</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham JM, Papadakis N, Evans J, et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004;63:2111&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">15596758</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong YH, Lee KW, Sung JJ, et al. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci 2004;227:73&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pubmed">15546594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob S, Finsterbusch J, Weishaupt JH, et al. Diffusion tensor imaging for long-term follow-up of corticospinal tract degeneration in amyotrophic lateral sclerosis. Neuroradiology 2003;45:598&#x2013;600</Citation><ArticleIdList><ArticleId IdType="pubmed">12904924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sach M, Winkler G, Glauche V, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127:340&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">14607785</ArticleId></ArticleIdList></Reference><Reference><Citation>Toosy AT, Werring DJ, Orrell RW, et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:1250&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1738665</ArticleId><ArticleId IdType="pubmed">12933929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulug AM, Grunewald T, Lin MT, et al. Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J Magn Reson Imaging 2004;19:34&#x2013;39</Citation><ArticleIdList><ArticleId IdType="pubmed">14696218</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki S, Iwata NK, Masutani Y, et al. Quantitative evaluation of the pyramidal tract segmented by diffusion tensor tractography: feasibility study in patients with amyotrophic lateral sclerosis. Radiat Med 2005;23:195&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">15940067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Poptani H, Woo JH, et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006;239:831&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">16641339</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H, Lim CC, Ma L, et al. Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol 2004;251:1249&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">15503106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Ulug AM, Pullman SL, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68:1402&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">17452585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan S, Kaufmann P, Shungu DC, et al. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am 2003;13:307&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">13677809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. What are the implications of early diagnosis? Maintaining optimal health as long as possible. Neurology 1999;53:S43&#x2013;S45</Citation><ArticleIdList><ArticleId IdType="pubmed">10560637</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. Earlier is better: the benefits of early diagnosis. Neurology 1999;53:S53&#x2013;S54</Citation><ArticleIdList><ArticleId IdType="pubmed">10560640</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodin DS, Rowley HA, Olney RK. Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol 1988;23:418&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">3382182</ArticleId></ArticleIdList></Reference><Reference><Citation>Udaka F, Sawada H, Seriu N, et al. MRI and SPECT findings in amyotrophic lateral sclerosis: demonstration of upper motor neurone involvement by clinical neuroimaging. Neuroradiology 1992;34:389&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">1407516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung G, Gawel MJ, Cooper PW, et al. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995;194:263&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pubmed">7997565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann E, Ochs G, Pelzl A, et al. The corticospinal tract in amyotrophic lateral sclerosis: an MRI study. Neuroradiology 1998;40:71&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pubmed">9541915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecht MJ, Fellner F, Fellner C, et al. MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images J Neurol Sci 2001;186:37&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">11412870</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecht MJ, Fellner F, Fellner C, et al. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 2002;199:59&#x2013;65</Citation><ArticleIdList><ArticleId IdType="pubmed">12084444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K, Nagura H, Yokota T, et al. Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Ann Neurol 1993;33:218&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">8434885</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993;189:843&#x2013;46</Citation><ArticleIdList><ArticleId IdType="pubmed">8234713</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Kaufmann J, Fradrich J, et al. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 2006;6:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1459868</ArticleId><ArticleId IdType="pubmed">16638121</ArticleId></ArticleIdList></Reference><Reference><Citation>Young S, Bystrov D, Netsch T, et al. Automated planning of MRI neuro scans. In: Reinhardt JM, Pluim JPW, eds. Medical Imaging 2006: Image Processing. San Diego, Calif, SPIE Medical Imaging;2006. :6144 (1),61441M-8</Citation></Reference><Reference><Citation>Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">11390270</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhamme L, van den BA, Van HS. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">9405214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xe4;ber F, Block W, Lamerichs R, et al. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004;19:537&#x2013;45</Citation><ArticleIdList><ArticleId IdType="pubmed">15112302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaermann T, Crelier G, Pruessmann KP, et al. SENSE-DTI at 3 T. Magn Reson Med 2004;51:230&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pubmed">14755645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S, Kaufmann WE, Davatzikos C, et al. Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med 2002;47:215&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">11810663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S, Crain BJ, Chacko VP, et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45:265&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">9989633</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieltjes B, Kaufmann WE, van Zijl PC, et al. Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage 2001;14:723&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">11506544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakana S, Jiang H, Nagae-Poetscher LM, et al. Fiber tract-based atlas of human white matter anatomy. Radiology 2004;230:77&#x2013;87</Citation><ArticleIdList><ArticleId IdType="pubmed">14645885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Melhem ER. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers. Ann N Y Acad Sci 2005;1064:61&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pubmed">16394148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Poptani H, Bilello M, et al. Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract. AJNR Am J Neuroradiol 2006;27:1234&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">16775271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage CA, Peeters RR, Gorner A, et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007;34:486&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">17097892</ArticleId></ArticleIdList></Reference><Reference><Citation>Provenzale J. Amyotrophic lateral sclerosis (ALS). In: Osborn AG, ed. Diagnostic Imaging Brain. 3rd ed. Salt Lake City, Utah: Amirsys Inc;2005. :I/10:86&#x2013;90</Citation></Reference><Reference><Citation>Karitzky J, Block W, Mellies JK, et al. Proton magnetic resonance spectroscopy in Kennedy syndrome. Arch Neurol 1999;56:1465&#x2013;71</Citation><ArticleIdList><ArticleId IdType="pubmed">10593301</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>